Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis.

GR Foster, WL Irving, MC Cheung, AJ Walker… - Journal of …, 2016 - europepmc.org
Methods Patients with HCV and decompensated cirrhosis or at risk of irreversible disease
were treated in an expanded access programme (EAP) in 2014. Treatment, by clinician …

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

GR Foster, WL Irving, M Cheung… - Journal of … - nottingham-repository.worktribe.com
© 2016 European Association for the Study of the Liver. Background & Aims All oral direct
acting antivirals (DAAs) effectively treat chronic hepatitis C virus (HCV) infection, but the …
[PDF] core.ac.uk

[PDF][PDF] Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

GR Foster, WL Irving, MCM Cheung, AJ Walker… - 2016 - core.ac.uk
Methods Patients with HCV and decompensated cirrhosis or at risk of irreversible disease
were treated in an Expanded Access Programme (EAP) in 2014. Treatment, by clinician …